87 related articles for article (PubMed ID: 12034566)
1. Protease-activated receptor-2 activating peptide SLIGRL inhibits bacterial lipopolysaccharide-induced recruitment of polymorphonuclear leukocytes into the airways of mice.
Moffatt JD; Jeffrey KL; Cocks TM
Am J Respir Cell Mol Biol; 2002 Jun; 26(6):680-4. PubMed ID: 12034566
[TBL] [Abstract][Full Text] [Related]
2. Effects of inhaled thrombin receptor agonists in mice.
Moffatt JD; Lever R; Page CP
Br J Pharmacol; 2004 Sep; 143(2):269-75. PubMed ID: 15302675
[TBL] [Abstract][Full Text] [Related]
3. Stimulation of protease-activated receptor-2 inhibits airway eosinophilia, hyperresponsiveness and bronchoconstriction in a murine model of allergic inflammation.
De Campo BA; Henry PJ
Br J Pharmacol; 2005 Apr; 144(8):1100-8. PubMed ID: 15700024
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory influence of the hexapeptidic sequence SLIGRL on influenza A virus infection in mice.
Betts RJ; Mann TS; Henry PJ
J Pharmacol Exp Ther; 2012 Dec; 343(3):725-35. PubMed ID: 22988062
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory influence of protease-activated receptor 2 and E-prostanoid receptor stimulants in lipopolysaccharide models of acute airway inflammation.
Peters T; Mann TS; Henry PJ
J Pharmacol Exp Ther; 2010 Nov; 335(2):424-33. PubMed ID: 20688975
[TBL] [Abstract][Full Text] [Related]
6. Proteinase-activated receptor-2-mediated matrix metalloproteinase-9 release from airway epithelial cells.
Vliagoftis H; Schwingshackl A; Milne CD; Duszyk M; Hollenberg MD; Wallace JL; Befus AD; Moqbel R
J Allergy Clin Immunol; 2000 Sep; 106(3):537-45. PubMed ID: 10984375
[TBL] [Abstract][Full Text] [Related]
7. Proteinase activated receptor 2: Role of extracellular loop 2 for ligand-mediated activation.
Al-Ani B; Saifeddine M; Kawabata A; Hollenberg MD
Br J Pharmacol; 1999 Nov; 128(5):1105-13. PubMed ID: 10556949
[TBL] [Abstract][Full Text] [Related]
8. Influence of dexamethasone on protease-activated receptor 2-mediated responses in the airways.
Saleh SM; Mann TS; Peters T; Betts RJ; Henry PJ
J Pharmacol Exp Ther; 2008 Feb; 324(2):622-30. PubMed ID: 18003863
[TBL] [Abstract][Full Text] [Related]
9. PPARalpha downregulates airway inflammation induced by lipopolysaccharide in the mouse.
Delayre-Orthez C; Becker J; Guenon I; Lagente V; Auwerx J; Frossard N; Pons F
Respir Res; 2005 Aug; 6(1):91. PubMed ID: 16091136
[TBL] [Abstract][Full Text] [Related]
10. Trypsin- and SLIGRL-induced vascular relaxation and the inhibition by benzamidine derivatives.
Glusa E; Saft A; Prasa D; Stürzebecher J
Thromb Haemost; 1997 Nov; 78(5):1399-403. PubMed ID: 9408026
[TBL] [Abstract][Full Text] [Related]
11. Proteinase-activated receptors: structural requirements for activity, receptor cross-reactivity, and receptor selectivity of receptor-activating peptides.
Hollenberg MD; Saifeddine M; al-Ani B; Kawabata A
Can J Physiol Pharmacol; 1997 Jul; 75(7):832-41. PubMed ID: 9315351
[TBL] [Abstract][Full Text] [Related]
12. C-C chemokine receptor 2 (CCR2) deficiency improves bleomycin-induced pulmonary fibrosis by attenuation of both macrophage infiltration and production of macrophage-derived matrix metalloproteinases.
Okuma T; Terasaki Y; Kaikita K; Kobayashi H; Kuziel WA; Kawasuji M; Takeya M
J Pathol; 2004 Dec; 204(5):594-604. PubMed ID: 15538737
[TBL] [Abstract][Full Text] [Related]
13. A protective role for proteinase activated receptor 2 in airways of lipopolysaccharide-treated rats.
Morello S; Vellecco V; Roviezzo F; Maffia P; Cuzzocrea S; Cirino G; Cicala C
Biochem Pharmacol; 2005 Dec; 71(1-2):223-30. PubMed ID: 16300746
[TBL] [Abstract][Full Text] [Related]
14. Protease-activated receptor-1 (PAR1) and PAR2 but not PAR4 mediate relaxations in lower esophageal sphincter.
Huang SC
Regul Pept; 2007 Jul; 142(1-2):37-43. PubMed ID: 17335921
[TBL] [Abstract][Full Text] [Related]
15. Proteinase-activated receptor-2 (PAR2): vascular effects of a PAR2-derived activating peptide via a receptor different than PAR2.
McGuire JJ; Dai J; Andrade-Gordon P; Triggle CR; Hollenberg MD
J Pharmacol Exp Ther; 2002 Dec; 303(3):985-92. PubMed ID: 12438518
[TBL] [Abstract][Full Text] [Related]
16. Protease-activated receptors: development of agonists selective for receptors triggered by either thrombin (PAR1) or trypsin (PAR2).
Kawabata A; Saifeddine M; al-Ani B; Hollenberg MD
Proc West Pharmacol Soc; 1997; 40():49-51. PubMed ID: 9436211
[No Abstract] [Full Text] [Related]
17. Involvement of neutrophil recruitment and protease-activated receptor 2 activation in the induction of IL-18 in mice.
Ikawa K; Nishioka T; Yu Z; Sugawara Y; Kawagoe J; Takizawa T; Primo V; Nikolic B; Kuroishi T; Sasano T; Shimauchi H; Takada H; Endo Y; Sugawara S
J Leukoc Biol; 2005 Nov; 78(5):1118-26. PubMed ID: 16260585
[TBL] [Abstract][Full Text] [Related]
18. Effect of respiratory syncytial virus on the activity of matrix metalloproteinase in mice.
Li W; Shen HH
Chin Med J (Engl); 2007 Jan; 120(1):5-11. PubMed ID: 17254480
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the inflammatory response induced by rhMMP-12 catalytic domain instilled in mouse airways.
Nénan S; Planquois JM; Berna P; De Mendez I; Hitier S; Shapiro SD; Boichot E; Lagente V; Bertrand CP
Int Immunopharmacol; 2005 Mar; 5(3):511-24. PubMed ID: 15683848
[TBL] [Abstract][Full Text] [Related]
20. A protective role for protease-activated receptors in the airways.
Cocks TM; Fong B; Chow JM; Anderson GP; Frauman AG; Goldie RG; Henry PJ; Carr MJ; Hamilton JR; Moffatt JD
Nature; 1999 Mar; 398(6723):156-60. PubMed ID: 10086357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
